Finding 480785 (2020-004)

Significant Deficiency
Requirement
A
Questioned Costs
-
Year
2020
Accepted
2024-08-09

AI Summary

  • Core Issue: Payroll approvals are not consistently made by supervisors or knowledgeable individuals, risking improper federal grant payments.
  • Impacted Requirements: This finding violates 2 CFR 200.303, which mandates effective internal controls for managing federal awards.
  • Recommended Follow-up: AAPT should ensure that payroll approvers are the actual supervisors or knowledgeable about employee efforts; changes are expected to be completed by 04/01/2024.

Finding Text

Finding 2020-004: Payroll Significant Deficiency Federal Programs: Research and Development Cluster: 47.076 Criteria or Specific Requirement (Including Statutory, Regulatory, or Other Citation): As noted in 2 CFR 200.303 “The non-Federal entity must establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).” Condition: Payroll approvals for individuals are not always made by individuals who are the employee’s supervisors or are otherwise knowledgeable about their level of effort during the payroll periods paid for. Cause: AAPT did not appropriately assign or ensure approval by payroll approvers based on who supervised or was otherwise knowledgeable of employee activity on federal grants. Effect or Potential Effect: Without an individual knowledgeable of an individual employee’s level of effort approving the time charged there is a greater risk that payroll payments are applied to a federal grant improperly, or leave is otherwise improperly omitted or overapplied to the individual’s leave balance. Questioned Costs: None noted. Identification as a Repeat Finding, if Applicable: Not a repeat finding. Recommendation: We recommend that AAPT change the designated approver for certain employees for whom the designated approver is not the employee’s supervisor or is not otherwise aware of the employee’s work efforts. Views of Responsible Officials and Planned Corrective Actions: AAPT has made changes to correctly reflect the employee’s assigned supervisor based on the position and job duties of the employees. Anticipated Completion Date: 04/01/2024 Responsible Official: Michael Brosnan, CFO

Corrective Action Plan

Finding 2020-004: Payroll Federal Programs: Research and Development Cluster: 47.0746 Condition: Payroll approvals for individuals are not always made by individuals who are the employee's supervisors or are otherwise knowledgeable about their level of effort during the payroll periods paid for. Views of Responsible Officials and Planned Corrective Actions: AAPT has made changes to correclty reflect the employee's assigned supervisor based on the position and job duties of the employees. Anticipated Completion Date: 04/01/2024 Responsible Official: Michael Brosnan, CFO

Categories

Matching / Level of Effort / Earmarking Significant Deficiency

Other Findings in this Audit

  • 480780 2020-003
    Material Weakness Repeat
  • 480781 2020-005
    Significant Deficiency Repeat
  • 480782 2020-003
    Material Weakness Repeat
  • 480783 2020-005
    Significant Deficiency Repeat
  • 480784 2020-003
    Material Weakness Repeat
  • 480786 2020-005
    Significant Deficiency Repeat
  • 480787 2020-003
    Material Weakness Repeat
  • 480788 2020-004
    Significant Deficiency
  • 480789 2020-005
    Significant Deficiency Repeat
  • 480790 2020-003
    Material Weakness Repeat
  • 480791 2020-005
    Significant Deficiency Repeat
  • 480792 2020-006
    Significant Deficiency Repeat
  • 480793 2020-003
    Material Weakness Repeat
  • 480794 2020-005
    Significant Deficiency Repeat
  • 480795 2020-003
    Material Weakness Repeat
  • 480796 2020-004
    Significant Deficiency
  • 480797 2020-005
    Significant Deficiency Repeat
  • 480798 2020-003
    Material Weakness Repeat
  • 480799 2020-005
    Significant Deficiency Repeat
  • 480800 2020-003
    Material Weakness Repeat
  • 480801 2020-005
    Significant Deficiency Repeat
  • 480802 2020-003
    Material Weakness Repeat
  • 480803 2020-005
    Significant Deficiency Repeat
  • 480804 2020-003
    Material Weakness Repeat
  • 480805 2020-005
    Significant Deficiency Repeat
  • 480806 2020-003
    Material Weakness Repeat
  • 480807 2020-005
    Significant Deficiency Repeat
  • 480808 2020-003
    Material Weakness Repeat
  • 480809 2020-005
    Significant Deficiency Repeat
  • 480810 2020-003
    Material Weakness Repeat
  • 480811 2020-005
    Significant Deficiency Repeat
  • 480812 2020-003
    Material Weakness Repeat
  • 480813 2020-005
    Significant Deficiency Repeat
  • 480814 2020-005
    Significant Deficiency Repeat
  • 480815 2020-005
    Significant Deficiency Repeat
  • 480816 2020-005
    Significant Deficiency Repeat
  • 1057222 2020-003
    Material Weakness Repeat
  • 1057223 2020-005
    Significant Deficiency Repeat
  • 1057224 2020-003
    Material Weakness Repeat
  • 1057225 2020-005
    Significant Deficiency Repeat
  • 1057226 2020-003
    Material Weakness Repeat
  • 1057227 2020-004
    Significant Deficiency
  • 1057228 2020-005
    Significant Deficiency Repeat
  • 1057229 2020-003
    Material Weakness Repeat
  • 1057230 2020-004
    Significant Deficiency
  • 1057231 2020-005
    Significant Deficiency Repeat
  • 1057232 2020-003
    Material Weakness Repeat
  • 1057233 2020-005
    Significant Deficiency Repeat
  • 1057234 2020-006
    Significant Deficiency Repeat
  • 1057235 2020-003
    Material Weakness Repeat
  • 1057236 2020-005
    Significant Deficiency Repeat
  • 1057237 2020-003
    Material Weakness Repeat
  • 1057238 2020-004
    Significant Deficiency
  • 1057239 2020-005
    Significant Deficiency Repeat
  • 1057240 2020-003
    Material Weakness Repeat
  • 1057241 2020-005
    Significant Deficiency Repeat
  • 1057242 2020-003
    Material Weakness Repeat
  • 1057243 2020-005
    Significant Deficiency Repeat
  • 1057244 2020-003
    Material Weakness Repeat
  • 1057245 2020-005
    Significant Deficiency Repeat
  • 1057246 2020-003
    Material Weakness Repeat
  • 1057247 2020-005
    Significant Deficiency Repeat
  • 1057248 2020-003
    Material Weakness Repeat
  • 1057249 2020-005
    Significant Deficiency Repeat
  • 1057250 2020-003
    Material Weakness Repeat
  • 1057251 2020-005
    Significant Deficiency Repeat
  • 1057252 2020-003
    Material Weakness Repeat
  • 1057253 2020-005
    Significant Deficiency Repeat
  • 1057254 2020-003
    Material Weakness Repeat
  • 1057255 2020-005
    Significant Deficiency Repeat
  • 1057256 2020-005
    Significant Deficiency Repeat
  • 1057257 2020-005
    Significant Deficiency Repeat
  • 1057258 2020-005
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
47.049 Mathematical and Physical Sciences $10,562
47.076 Education and Human Resources $6,442
43.001 Science $4,172